Cannabinoid compositions for the treatment of post-traumatic epilepsy
CO20260010424A2Pending Publication Date: 2026-08-20BIOPHARMACEUTICAL RESEARCH COMPANY
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CO20260010424
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-20
- Filing Date
- 2026-07-21
- Publication Date
- 2026-08-20
Abstract
Cannabinoid compositions formulated for use in the treatment of post-traumatic epilepsy (PTE) are disclosed. These compositions include cannabidiol (CBD), cannabigerol (CBG), and tetrahydrocannabinol (THC) as their main components, which may be isolated, purified, or extracted from cultivars and mixed together. The compositions include CBD, CBG, and THC in specific proportions, formulated for use in the treatment of PTE.
Need to check novelty before this filing date? Find Prior Art